MangoRx vs NowPatient
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
MangoRx
Best for pending product verificationStarting at $199/mo
NowPatient
Best for Brand-name GLP-1 access without a compounded routeStarting at $1069/mo
Side-by-Side Comparison
| Feature | MangoRx | NowPatient |
|---|---|---|
| Overall Score | ✓7.1/10 | 6.8/10 |
| Starting Price | ✓$199/mo | $1069/mo |
| Editorial Rating | ✓3.6 ★ /5 | 3.4 ★ /5 |
| Features | ✓3 features | 2 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
MangoRx
Pros
- ✓Katalys-approved program at 14% commission — attractive on higher AOV orders
- ✓Men's-health-focused telehealth — bundled GLP-1 + TRT + ED + hair lets a single user fill multiple needs through one provider
Cons
- ✗Stub entry — exact GLP-1 drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
- ✗Cross-selling TRT alongside GLP-1s is editorially worth disclosing — readers looking specifically for weight loss may not want to be funneled into a men's-hormone broader program
NowPatient
Pros
- ✓Free telehealth consultation — patients only pay the medication cost
- ✓Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- ✓One of the few telehealth platforms offering Wegovy in both injection and oral pill form
- ✓No compounded options — every drug is FDA-approved brand
Cons
- ✗Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
- ✗Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
- ✗State availability not disclosed publicly — determined during intake
- ✗Phone: 1-866-967-1977, HQ Austin TX
- ✗Does NOT offer Foundayo (orforglipron)
Our Verdict
MangoRx edges out NowPatient with a higher overall score of 7.1/10 and is particularly strong for pending product verification. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.